1. Following Endocardial Tissue Movements via Cell Photoconversion in the Zebrafish Embryo
- Author
-
Renee Wei-Yan Chow, Emily Steed, Francesco Boselli, Paola Lamperti, Julien Vermot, univOAK, Archive ouverte, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), and Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Heart development ,Cardiac cycle ,General Immunology and Microbiology ,Organogenesis ,General Chemical Engineering ,General Neuroscience ,Embryogenesis ,Embryonic Development ,Biology ,biology.organism_classification ,General Biochemistry, Genetics and Molecular Biology ,Cell biology ,medicine.anatomical_structure ,[SDV.BDD] Life Sciences [q-bio]/Development Biology ,medicine ,Animals ,Atrioventricular canal ,Heart valve ,Developmental biology ,Zebrafish ,[SDV.BDD]Life Sciences [q-bio]/Development Biology ,Preclinical imaging ,Endocardium ,Developmental Biology - Abstract
During embryogenesis, cells undergo dynamic changes in cell behavior, and deciphering the cellular logic behind these changes is a fundamental goal in the field of developmental biology. The discovery and development of photoconvertible proteins have greatly aided our understanding of these dynamic changes by providing a method to optically highlight cells and tissues. However, while photoconversion, time-lapse microscopy, and subsequent image analysis have proven to be very successful in uncovering cellular dynamics in organs such as the brain or the eye, this approach is generally not used in the developing heart due to challenges posed by the rapid movement of the heart during the cardiac cycle. This protocol consists of two parts. The first part describes a method for photoconverting and subsequently tracking endocardial cells (EdCs) during zebrafish atrioventricular canal (AVC) and atrioventricular heart valve development. The method involves temporally stopping the heart with a drug in order for accurate photoconversion to take place. Hearts are allowed to resume beating upon removal of the drug and embryonic development continues normally until the heart is stopped again for high-resolution imaging of photoconverted EdCs at a later developmental time point. The second part of the protocol describes an image analysis method to quantify the length of a photoconverted or non-photoconverted region in the AVC in young embryos by mapping the fluorescent signal from the three-dimensional structure onto a two-dimensional map. Together, the two parts of the protocol allows one to examine the origin and behavior of cells that make up the zebrafish AVC and atrioventricular heart valve, and can potentially be applied for studying mutants, morphants, or embryos that have been treated with reagents that disrupt AVC and/or valve development.
- Published
- 2018